logo
#

Latest news with #GeniusAI

Hologic Rides on AI-Powered Breast Health Innovations: What's Next?
Hologic Rides on AI-Powered Breast Health Innovations: What's Next?

Yahoo

time16-07-2025

  • Business
  • Yahoo

Hologic Rides on AI-Powered Breast Health Innovations: What's Next?

Breast cancer continues to be a significant global health challenge and the leading cause of cancer-related deaths among women. Artificial Intelligence is playing an increasingly vital role in addressing this issue, which involves managing clinical data, identifying ambiguous cases, forecasting patient outcomes and enabling more informed clinical decisions. U.S. medical device maker Hologic HOLX has long been at the forefront of using AI to enhance accuracy and efficiency for radiologists. In 2009, the company set a new standard in breast cancer screening with the launch of its Genius 3D mammography exam — the only FDA-approved mammogram clinically proven to be superior to 2D mammography for all women, including those with dense breast tissue. While Hologic is navigating a softer year in capital equipment sales, it continues to hold a leading share of the U.S. mammography market. At the core of the company's breast health offerings is its Genius AI platform, designed to enhance cancer detection, operational efficiency and support clinical decisions. The platform also powers the 3DQuorum technology, approved by the FDA in 2019, which delivers meaningful productivity gains for radiologists due to a significant reduction in read time. Despite widespread adoption of AI tools in breast cancer screening, many algorithms have exhibited racial disparities across applications. Hologic's Genius AI Detection 2.0 solution stands out, with research confirming consistent results across diverse populations. Building on this, the company is set to launch its Genius AI Detection PRO solution in the United States, promising even greater accuracy and fewer false positives. The next-generation solution was recently named 'Best New Imaging Technology Solution' by MedTech Breakthrough, reinforcing Hologic's leadership in breast imaging AI. Furthermore, HOLX is preparing for the commercial launch of the Envision Mammography Platform, which provides a high-speed 3D mammogram with a 2.5-second scan time — the fastest in the market. GE Healthcare GEHC boasts the largest global footprint of breast imaging systems, with a portfolio that includes 2D and 3D Mammography, Ultrasound, Automated Breast Ultrasound (ABUS), MRI, CT and PET/CT. GEHC's recent innovations include the Pristina Via mammography system, which enhances the screening experience for both technologists and patients, and the Invenia ABUS Premium — a 3D ultrasound with advanced AI and features to drive faster, reproducible supplemental screening and simplify exam readings on patients with dense breasts. RadNet RDNT, via its subsidiary DeepHealth, recently acquired See-Mode Technologies PTE LTD. The acquisition adds AI-powered ultrasound detection, characterization and reporting solutions for thyroid and breast to DeepHealth's population health solutions. Furthermore, in April 2025, RadNet announced that it would acquire iCAD, known for its clinically proven AI-powered breast health solutions, in an all-stock transaction. iCAD will also be integrated into the DeepHealth portfolio of solutions. Year to date, Hologic shares have declined 12.3% compared with the industry's 10.2% fall. Image Source: Zacks Investment Research Hologic is trading at a forward three-year price-to-earnings of 14.25X, discounted than the industry average of 28.35X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research Consensus estimates for EPS have dropped 0.5% for fiscal 2025 and 1.1% for 2026 over the past 60 days. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hologic, Inc. (HOLX) : Free Stock Analysis Report RadNet, Inc. (RDNT) : Free Stock Analysis Report GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Lewis County Health System debuts new 3D mammography technology
Lewis County Health System debuts new 3D mammography technology

Yahoo

time21-04-2025

  • Health
  • Yahoo

Lewis County Health System debuts new 3D mammography technology

LOWVILLE, N.Y. (WWTI) – The Lewis County Health System has debuted new three-dimensional mammography technology. In a recent announcement, LCHS has announced the installation of the Hologic 3D Dimensions mammography system with Genius AI. This brings state-of-the-art breast cancer screening technology to the Lewis County community. The 'cutting-edge system enhances early detection, improves diagnostic accuracy, and provides a more comfortable experience for patients.' Some breast cancer patients can avoid certain surgeries, studies suggest Over the last eight years, the health system has consistently invested in new equipment and technology. With this latest investment, women have access to the highest level of breast health technology in the region and don't have to travel out of the area to access needed care. Gerald R. Cayer, LCHS Chief Executive The Hologic 3D Dimensions system with Genius AI represents the latest advancement in breast imaging, offering: Superior 3D Mammography – Detects breast cancer earlier with clearer, more detailed images. Genius AI™ Technology – Uses artificial intelligence to assist radiologists in identifying potential abnormalities faster and with greater precision. Reduced Need for Additional Imaging – Lowers recall rates, meaning fewer patients need to return for unnecessary follow-up exams. Enhanced Comfort – Designed with SmartCurve technology, providing a more comfortable mammogram experience without compromising image quality. According to LCHS, breast cancer remains the most common cancer among women, and early detection is critical for successful treatment. With this new technology, LCHS continues its commitment to delivering the most advanced, accurate, and patient-friendly breast imaging services in the region. For more information about breast health services, call 315-376-5213 or visit Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store